Page last updated: 2024-10-22

ag-1296 and Carotid Stenosis

ag-1296 has been researched along with Carotid Stenosis in 1 studies

6,7-dimethoxy-3-phenylquinoxaline: ATP-competitive inhibitor of receptor kinase

Carotid Stenosis: Narrowing or stricture of any part of the CAROTID ARTERIES, most often due to atherosclerotic plaque formation. Ulcerations may form in atherosclerotic plaques and induce THROMBUS formation. Platelet or cholesterol emboli may arise from stenotic carotid lesions and induce a TRANSIENT ISCHEMIC ATTACK; CEREBROVASCULAR ACCIDENT; or temporary blindness (AMAUROSIS FUGAX). (From Adams et al., Principles of Neurology, 6th ed, pp 822-3)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fishbein, I1
Chorny, M1
Banai, S1
Levitzki, A1
Danenberg, HD1
Gao, J1
Chen, X1
Moerman, E1
Gati, I1
Goldwasser, V1
Golomb, G1

Other Studies

1 other study available for ag-1296 and Carotid Stenosis

ArticleYear
Formulation and delivery mode affect disposition and activity of tyrphostin-loaded nanoparticles in the rat carotid model.
    Arteriosclerosis, thrombosis, and vascular biology, 2001, Volume: 21, Issue:9

    Topics: Animals; Carotid Arteries; Carotid Stenosis; Chemistry, Pharmaceutical; Drug Delivery Systems; Male;

2001